Gore Joins Americas Hernia Society Quality Collaborative (AHSQC) as Silver Sponsor
Partnership latest step in Gore’s ongoing commitment to improve quality of care for hernia patients
Gore Global Registry for Endovascular Aortic Treatment Completes Enrollment
Over 5,000 patients from 114 worldwide sites provide a unique perspective of real-world conditions
GORE® TIGRIS® Vascular Stent Gains FDA Approval for Treatment of Peripheral Artery Disease
Novel device combines proven technology with modern adaptations to provide support in even the most challenging anatomies
Now Published in the Annals of Surgery: Long-Term Favorable Results Demonstrate GORE® BIO-A® Tissue Reinforcement Efficacy in Complex Ventral Hernia Repairs
Final study results demonstrate for the first time efficacy of long-lasting absorbable biosynthetic mesh in challenging hernia repairs; has potential to end biologics era in hernia repair
First Patient Enrolled in Gore® SCAFFOLD Clinical Study for Carotid Stenting
Pivotal Multicenter Investigational Study Begins at Medical University of South Carolina (MUSC), Evaluating Safety and Efficacy of Innovative GORE® Carotid Stent
Unique Biomaterial for Hernia Repair Receives FDA 510K Clearance
GORE® SYNECOR Biomaterial combines strength of PTFE with the tissue-building scaffold of GORE® BIO-A® Web to create an improved device for hernia repair
GORE® VIABAHN® Endoprosthesis Marks 20 Years of Proven Performance
Market-leading stent-graft has evolved to address range of indications, patient needs
FDA Approves First Balloon Expandable Stent Graft for Use in the Iliac Artery
GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Provides Improved Outcomes in Real-World Peripheral Arterial Disease Cases
GORE® TIGRIS® Vascular Stent Gains Health Canada Approval for Treatment of Peripheral Artery Disease
Novel device combines proven technology with modern adaptations to provide support in even the most challenging anatomies
W. L. Gore & Associates Receives Innovative Technology Designation from Vizient, Inc. for GORE® SYNECOR Biomaterial
Designation recognizes products that bring improvements to the healthcare industry